The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Mótyán, J. A.,
Golda, M.,
Mahdi, M.,
Nashed, N. T.,
Louis, J. M.,
Tőzsér, J.:
Molecular mechanisms of protease precursor autoprocessing of RNA viruses: a comprehensive review.
Virol. J. 23 (1), 1-23, (article identifier: 96), 2026.
Kiarie, I. W.,
Hoffka, G.,
Laporte, M.,
Leyssen, P.,
Neyts, J.,
Tőzsér, J.,
Mahdi, M.:
Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2.
Viruses-Basel. 16 (10), 1-15, (article identifier: 1607), 2024.
Golda, M.,
Hoffka, G.,
Cherry, S.,
Tropea, J. E.,
Lountos, G. T.,
Waugh, D. S.,
Wlodawer, A.,
Tőzsér, J.,
Mótyán, J. A.:
P1' specificity of the S219V/R203G mutant tobacco etch virus protease.
Proteins. 92 (9), 1085-1096, 2024.
Mótyán, J. A.,
Tőzsér, J.:
The human retroviral-like aspartic protease 1 (ASPRV1): from in vitro studies to clinical correlations.
J. Biol. Chem. 300 (9), 1-16, (article identifier: 107634), 2024.
Papp, H.,
Tóth, E.,
Bóvári-Biri, J.,
Bánfai, K.,
Juhász, P.,
Mahdi, M.,
Russo, L. C.,
Bajusz, D.,
Sipos, A.,
Petri, L.,
Szalai, T. V.,
Kemény, Á.,
Madai, M.,
Kuczmog, A.,
Batta, G.,
Mózner, O.,
Vaskó, D.,
Hirsch, E.,
Bohus, P.,
Méhes, G.,
Tőzsér, J.,
Curtin, N.,
Helyes, Z.,
Tóth, A.,
Hoch, N. C.,
Jakab, F.,
Keserű, G. M.,
Pongrácz, J.,
Bai, P.:
The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
Br. J. Pharmacol. 181 (23), 4782-4803, 2024.
Hoffka, G.,
Lountos, G. T.,
Needle, D.,
Wlodawer, A.,
Waugh, D. S.,
Tőzsér, J.,
Mótyán, J. A.:
Self-inhibited state of Venezuelan equine encephalitis virus (VEEV) nsP2 cysteine protease: a crystallographic and molecular dynamics analysis.
J. Mol. Biol. 435 (6), 1-20, 2023.
